Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
- 12 June 1993
- Vol. 306 (6892) , 1610-1611
- https://doi.org/10.1136/bmj.306.6892.1610-c
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Respiratory arrests in young asthmatics on salmeterolRespiratory Medicine, 1993
- Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.BMJ, 1993
- Dose equivalence of drugs for asthma.BMJ, 1993
- Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.BMJ, 1993
- Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.Thorax, 1993
- A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate AsthmaNew England Journal of Medicine, 1992
- Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease — a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol (50 μg)Respiratory Medicine, 1992
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990
- Patients at risk for dying of asthma: New Zealand experienceJournal of Allergy and Clinical Immunology, 1987